Letter

Suboptimal prescribing in gout

Patient related factors are also important in treating gout

BMJ 2012; 344 doi: 10.1136/bmj.e191 (Published 10 January 2012)
Cite this as: BMJ 2012;344:e191

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Priyanka Chandratre, clinical research training fellow and honorary specialist registrar in rheumatology1,
  2. Edward Roddy, clinical senior lecturer in rheumatology and honorary consultant rheumatologist1,
  3. Christian Mallen, professor of general practice1
  1. 1Arthritis Research UK Primary Care Centre, Keele University, Keele ST5 5BG, UK
  1. p.chandratre{at}cphc.keele.ac.uk

The treatment of gout remains suboptimal—only 30% of primary care patients take urate lowering drugs.1 Lipworth and colleagues note that important reasons for this underuse include drug toxicity and poor patient adherence owing to the introduction of these drugs provoking gout attacks.2

However, the views and beliefs of patients about gout and urate lowering drugs also …

Access to the full text of this article requires a subscription or payment

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Rapid responses

THIS WEEK'S POLL

Read related article

See previous polls

BMJ most popular